RxDoctor Payments DataLook up a doctor →

Alfred Moss, MD

Adult Medicine · Gaffney, SCNPI 1245294107

Payments from drug & device makers

$14,344in general payments, 2019–2025

Across 767 payments — averaging $18.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • AbbVie$2K
  • Amgen$1K
  • Pfizer$1K
  • Novo Nordisk$754
  • Antares Pharma, Inc.$732
  • plus $7K from 53 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca93$1,981
AbbVie(2 entities)114$1,708
Amgen(2 entities)39$1,153
Pfizer64$1,108
Novo Nordisk50$754
Antares Pharma, Inc.49$732
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC43$688
Lilly USA, LLC45$668
GSK28$613
Forte Bio-pharma LLC7$392
Biohaven Pharmaceutical Holding Company Ltd.20$385
Bayer19$306
Novartis18$300
Biohaven Pharmaceuticals, Inc.9$293
Sunovion Pharmaceuticals Inc.21$252
Boehringer Ingelheim14$232
Axsome Therapeutics, Inc.6$223
Daiichi Sankyo Inc.6$201
Amarin Pharma, Inc.11$178
Aytu Biopharma, Inc.10$147
Galderma Laboratories, L.p.2$138
Phathom Pharmaceuticals, Inc.8$137
Ironshore Pharmaceuticals Inc.1$137
Mannkind Corporation7$128
Lundbeck LLC6$128
Sanofi-aventis U.S. LLC5$100
Takeda Pharmaceuticals U.S.A., Inc.6$95
Eisai Inc.6$93
Dermira, Inc.1$75
Upsher-smith Laboratories LLC4$75
Kowa Pharmaceuticals America, Inc.4$72
Supernus Pharmaceuticals, Inc.3$70
Astellas Pharma US Inc4$69
Otsuka America Pharmaceutical, Inc.3$62
Abbott4$60
Clarus Therapeutics Inc.5$50
Verity Pharmaceuticals Inc.2$45
Harmony Biosciences LLC1$45
Ironwood Pharmaceuticals, Inc2$39
Merck3$38
Mylan Specialty L.p.2$38
Acerus Pharmaceuticals Corporation2$35
Scilex Pharmaceuticals Inc.2$30
Halozyme Inc2$29
Idorsia Pharmaceuticals US Inc2$29
Ardelyx, Inc.1$21
Avanos Medical1$20
Indivior Inc.1$20
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$18
Avanir Pharmaceuticals, Inc.1$17
E.r. Squibb & Sons, L.L.C.1$17
Exact Sciences1$16
Currax Pharmaceuticals LLC1$15
Arcutis Biotherapeutics, Inc.1$14
Shire North American Group Inc1$14
MDD US Operations, LLC1$12
Impel Pharmaceuticals Inc.1$12
Johnson & Johnson1$12
Intra-sana Laboratories1$9

How this compares

Too few adult medicine providers in South Carolinato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$88,367
Medicare patients
151
Services billed
1,410

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other adult medicine in Gaffney

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →